| Literature DB >> 35309190 |
Shengtao Dong1,2, Yinghui Zhu1,3, Hua Yang4, Ningyu Tang1, Guangyi Huang2, Jie Li1, Kang Tian1.
Abstract
Background: An increasing number of geriatric patients are suffering from degenerative lumbar spondylolisthesis (DLS) and need a lumbar interbody fusion (LIF) operation to alleviate the symptoms. Our study was performed aiming to determine the predictors that contributed to unfavorable clinical efficacy among patients with DLS after LIF according to the support vector machine (SVM) algorithm.Entities:
Keywords: clinical outcome; degenerative lumbar spondylolisthesis; lumbar interbody fusion; machine learning; predictor
Mesh:
Year: 2022 PMID: 35309190 PMCID: PMC8927688 DOI: 10.3389/fpubh.2022.835938
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1A schematic diagram of spinopelvic parameters, lumbar parameters, and lateral listhesis (LLS). Spinopelvic parameters (A) included pelvic incidence (PI), pelvic tilt (PT), and sacral slope (SS). Lumbar parameters (B) included lumbar lordosis (LL), segment lordosis (SL), slip degree (SD), and disc height (DH). Lateral listhesis (LLS) was measured according to (C).
Figure 2A schematic diagram of insertion depth; the patients were assigned to the S group (the screws accounted for 60–80% of the anteroposterior diameter of vertebral body) and the L group (the screws accounted for more than 80% of the anteroposterior diameter of vertebral body).
Figure 3A schematic diagram of the facet angle. A facet line was drawn between the 2 end points of each facet. The angle was measured between the facet line and the line connecting the bilateral dorsal points and recorded the average value.
Figure 4The lumbar spine model and the instrumentations after TLIF technique (the interbody fusion cage and the pedicle screw).
Demonstrative information of the patient cohort.
|
|
|
|---|---|
| Age (years), mean ± SD | 63.84 ± 8.23 |
| Sex (male/female), | 52 (33.12%)/ 105 (66.88%) |
| BMI (kg/m2), mean ± SD | 24.39 ± 2.32 |
| Smoking, | 23 (14.65%) |
| Diabetes mellitus, | 26 (16.56%) |
| Osteoporosis, | 43 (27.39%) |
| L3/4 | 18 (11.46%) |
| L4/5 | 75 (47.77%) |
| L5/S1 | 64 (40.77%) |
| TLIF | 82 (52.23%) |
| PLIF | 52 (33.12%) |
| TLIF + PLIF | 23 (14.65%) |
|
| |
| Autograft bone | 78 (49.68%) |
| Allograft bone | 41 (26.12%) |
| Autograft + allograft bones | 38 (24.20%) |
| Cement augmentation, | 52 (33.12%) |
| Screw retraction, | 2 (1.27%) |
| Fusion rate (fused/unfused), | 150 (95.54%)/ 7 (4.46%) |
| Short-term unfavorable cohort, | 26 (16.56%) |
| Long-term unfavorable cohort, | 9 (5.73%) |
Description of changes in DOI and VAS scores.
|
|
|
|
|
|---|---|---|---|
| ODI score | 63.93 ± 10.35 | 28.95 ± 10.01 (26.89/ 39.35) | 8.17 ± 3.20 (7.89 /12.78) |
| VAS score | 6.96 ± 1.20 | 2.78 ± 1.26 (2.49/ 4.23) | 0.69 ± 0.67 (0.64 /1.44) |
F, favorable clinical outcomes; UF, unfavorable clinical outcomes.
Comparison of the radiologic variables.
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| |||||||
| Preop | 8.60 ± 2.80 | 8.40 ± 2.80 | 9.60 ± 2.63 | 0.045 | 8.57 ± 2.81 | 9.00 ± 2.71 | 0.659 |
| Postop | 5.70 ± 1.84 | 5.22 ± 1.43 | 8.11 ± 1.75 | <0.001 | 5.57 ± 1.79 | 7.84 ± 1.14 | <0.001 |
|
| |||||||
| Preop | 7.67 ± 3.09 | 6.83 ± 2.01 | 11.89 ± 4.02 | <0.001 | 7.43 ± 2.91 | 11.56 ± 3.50 | <0.001 |
| Postop | 1.98 ± 0.73 | 1.93 ± 0.63 | 2.24 ± 1.09 | 0.172 | 1.95 ± 0.70 | 2.53 ± 0.84 | 0.021 |
|
| |||||||
| Preop | 17.76 ± 2.85 | 17.72 ± 2.86 | 17.94 ± 2.74 | 0.733 | 17.77 ± 2.87 | 17.51 ± 2.37 | 0.789 |
| Postop | 6.86 ± 1.70 | 6.83 ± 1.72 | 7.00 ± 1.61 | 0.629 | 6.82 ± 1.68 | 7.40 ± 1.89 | 0.326 |
|
| |||||||
| Preop | 38.87 ± 2.25 | 38.83 ± 2.26 | 39.10 ± 2.17 | 0.581 | 38.92 ± 2.24 | 38.16 ± 2.27 | 0.327 |
| Postop | 45.26 ± 2.52 | 45.34 ± 2.51 | 44.89 ± 2.54 | 0.413 | 45.30 ± 2.53 | 44.62 ± 2.33 | 0.435 |
|
| |||||||
| Preop | 16.40 ± 2.79 | 16.43 ± 2.87 | 16.24 ± 2.37 | 0.729 | 16.38 ± 2.82 | 16.66 ± 2.26 | 0.778 |
| Postop | 24.64 ±1.65 | 24.77 ± 1.67 | 24.01 ± 1.38 | 0.020 | 24.67 ± 1.67 | 24.28 ± 1.13 | 0.501 |
|
| |||||||
| Preop | 36.10 ± 2.30 | 36.20 ± 2.26 | 35.61 ± 2.42 | 0.234 | 36.10 ± 2.29 | 36.13 ± 2.37 | 0.973 |
| Postop | 37.81 ± 2.83 | 38.08 ± 2.78 | 36.48 ± 2.72 | 0.008 | 37.87 ± 2.81 | 36.83 ± 3.04 | 0.286 |
|
| |||||||
| Preop | 54.14 ± 2.57 | 54.31 ± 2.54 | 53.30 ± 2.56 | 0.068 | 54.22 ± 2.58 | 52.78 ± 1.95 | 0.104 |
| Postop | 52.87 ± 2.39 | 52.94 ± 2.41 | 52.49 ± 2.27 | 0.377 | 52.91 ± 2.41 | 52.18 ± 1.94 | 0.377 |
|
| |||||||
| Preop | 18.03 ± 2.76 | 17.97 ± 2.77 | 18.31 ± 2.69 | 0.572 | 18.03 ± 2.75 | 18.06 ± 3.04 | 0.977 |
| Postop | 15.17 ± 1.44 | 15.06 ± 1.43 | 15.78 ± 1.37 | 0.020 | 15.14 ± 1.43 | 15.76 ± 1.49 | 0.208 |
| Facet angle (°) | 57.71 ± 7.29 | 55.15 ± 6.07 | 64.59 ± 7.79 | <0.001 | 56.29 ± 6.95 | 63.65 ± 9.01 | 0.003 |
|
| 0.010 | 0.627 | |||||
| S group | 103 (65.61%) | 80 (61.07%) | 23 (88.46%) | 96 (64.87%) | 7 (77.78%) | ||
| L group | 54 (34.39%) | 51 (38.93%) | 3 (11.54%) | 52 (35.13%) | 2 (22.22%) | ||
Preop, preoperative; Postop, postoperative; DH, disc height; LLS, lateral listhesis; SD, slip degree; LL, lumbar lordosis; SL, segment lordosis; SS, sacral slope; PI, pelvic incidence; PT, pelvic tilt; S group, the screws account for 60–80% of the anteroposterior diameter of vertebral body; L group, the screws accounted for more than 80% of the anteroposterior diameter of vertebral body.
Univariate and multivariate logistic regression analysis of unfavorable clinical outcomes in the short-term cohort.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
|
|
|
|
|
|
| |||
|
|
|
|
| |||||
| Preop. DH | 1.17 | 1.00 | 1.36 | 0.048 | 0.98 | 0.67 | 1.41 | 0.894 |
| Preop. LLS | 2.11 | 1.51 | 2.97 | <0.001 | 2.01 | 1.23 | 3.28 | 0.005 |
| Postop. DH | 3.28 | 2.11 | 5.10 | <0.001 | 2.81 | 1.40 | 5.65 | 0.004 |
| Postop. LLS | 1.78 | 1.00 | 3.15 | 0.050 | 0.87 | 0.24 | 3.25 | 0.855 |
| Postop. SL | 0.74 | 0.56 | 0.98 | 0.037 | 1.01 | 0.59 | 1.71 | 0.979 |
| Postop. SS | 0.81 | 0.69 | 0.95 | 0.011 | 0.72 | 0.47 | 1.10 | 0.133 |
| Postop. PT | 1.44 | 1.05 | 1.97 | 0.023 | 1.23 | 0.64 | 2.36 | 0.544 |
|
| ||||||||
| S group | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| L group | 0.21 | 0.06 | 0.72 | 0.013 | 0.83 | 0.08 | 9.12 | 0.902 |
| Facet angle | 1.23 | 1.13 | 1.34 | <0.001 | 1.20 | 1.02 | 1.41 | 0.030 |
OR, odds ratio; 95% CI, 95% confidence interval.
Univariate and multivariate logistic regression analysis of unfavorable clinical outcomes in the long-term cohort.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
|
|
|
|
|
|
| |||
|
|
|
|
| |||||
| Preop. DH | 1.06 | 0.83 | 1.34 | 0.657 | 0.88 | 0.65 | 1.20 | 0.431 |
| Preop. LLS | 1.33 | 1.13 | 1.57 | 0.001 | 1.24 | 0.98 | 1.57 | 0.069 |
| Postop. DH | 1.77 | 1.25 | 2.50 | 0.001 | 1.60 | 1.02 | 2.49 | 0.038 |
| Postop. LLS | 2.80 | 1.13 | 6.98 | 0.027 | 1.43 | 0.55 | 3.69 | 0.465 |
| Postop. SL | 0.86 | 0.56 | 1.32 | 0.864 | 1.14 | 0.67 | 1.94 | 0.619 |
| Postop. SS | 0.88 | 0.68 | 1.12 | 0.289 | 0.91 | 0.67 | 1.24 | 0.566 |
| Postop. PT | 1.37 | 0.84 | 2.24 | 0.214 | 1.03 | 0.58 | 1.82 | 0.919 |
|
| ||||||||
| S group | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| L group | 0.53 | 0.11 | 2.63 | 0.435 | 1.58 | 0.23 | 10.93 | 0.645 |
| Facet angle | 1.14 | 1.04 | 1.25 | 0.006 | 1.03 | 0.92 | 1.16 | 0.557 |
OR, odds ratio; 95% CI, 95% confidence interval.
Figure 5In the short-term cohort, receiver operation characteristic (ROC) curve analysis of the SVM model with the maximum value of 0.96 (A); ROC curve analysis of 10-fold cross validation of the SVM model for predicting the risk of unfavorable clinical outcomes following LIF with average AUC of 0.88 and max AUC of 0.96 (B); confusion matrix of the SVM model (C).
Figure 6In the long-term cohort, receiver operation characteristic (ROC) curve analysis of the SVM model with the maximum value of 0.82 (A); ROC curve analysis of 10-fold cross validation of the SVM model for predicting the risk of unfavorable clinical outcomes, following LIF with average AUC of 0.78 and max AUC of 0.82 (B); confusion matrix of the SVM model (C).